Commitments and Contingencies Liabilities (Details) $ / shares in Units, € in Thousands |
1 Months Ended | 12 Months Ended | ||||||
---|---|---|---|---|---|---|---|---|
Apr. 07, 2022 |
Aug. 03, 2016 |
Dec. 20, 2021
$ / shares
shares
|
Dec. 31, 2022
USD ($)
shares
|
Dec. 31, 2022
EUR (€)
shares
|
Dec. 31, 2020
USD ($)
|
Dec. 31, 2021
USD ($)
|
Oct. 31, 2021
USD ($)
|
|
Commitments and Contingencies Liabilities (Details) [Line Items] | ||||||||
Royalty payments, percentage | 2.75% | |||||||
Payment of total proceeds from consideration, percentage | 213.00% | |||||||
Option to purchase ordinary shares (in Shares) | shares | 25,080 | |||||||
Service agreement with a consultant description | Subject to satisfactory completion of the Homologation Process no later than 12 months as of the Triggering Event, the Company shall pay the Consultant a onetime bonus payment of NIS 150,000, plus VAT (approximately $47) (the “Homologation Bonus”). -Subject to satisfactory completion of Commercial Sales, no later than 18 months as of the Triggering Event, the Company shall pay the Consultant a onetime bonus payment of NIS 350,000, plus VAT (approximately $109) (the “Commercial Bonus”). | Subject to satisfactory completion of the Homologation Process no later than 12 months as of the Triggering Event, the Company shall pay the Consultant a onetime bonus payment of NIS 150,000, plus VAT (approximately $47) (the “Homologation Bonus”). -Subject to satisfactory completion of Commercial Sales, no later than 18 months as of the Triggering Event, the Company shall pay the Consultant a onetime bonus payment of NIS 350,000, plus VAT (approximately $109) (the “Commercial Bonus”). | ||||||
Exercise price (in Dollars per share) | $ / shares | $ 6.1393 | |||||||
Payment of monthly remuneration amount | $ 3,000 | |||||||
Company total amount | 471 | € 397 | ||||||
Development and sales | 471,000 | |||||||
Installation and operation | 125,000 | € 110 | $ 409,000 | |||||
Revenues | 417,000 | |||||||
Deferred revenues in other accounts payable | 202,000 | |||||||
Capital cost | $ 87,000 | |||||||
Deferred revenue in the amount of other accounts payable | $ 87,000 | |||||||
Additional payments | $ 219,000 | |||||||
IPO [Member] | ||||||||
Commitments and Contingencies Liabilities (Details) [Line Items] | ||||||||
Period of first commercial sale | 5 years | |||||||
Payment of total proceeds from consideration, percentage | 1.50% | |||||||
Payment of total proceeds from consideration, percentage | 1.50% | |||||||
Option to purchase ordinary shares (in Shares) | shares | 195,448 | 195,448 | ||||||
Knorr-Bremse Rail Systems Schweiz AG [Member] | ||||||||
Commitments and Contingencies Liabilities (Details) [Line Items] | ||||||||
Payment of operational function test | $ 292,000 | € 244 | ||||||
Deferred revenues in other accounts payable | € | € 192 |